The opportunities for expanded NBS have included studies of SCID [1163,1164,1165], LSDs [1121,1166,1167,1168], SMA [1169], and Prader–Willi and Angelman syndromes [1170]. The gene discussed is SMN1; the disease is Angelman syndrome.